Feasibility and Acceptability of Amani

Clinical trial NCT07648043 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07648043
Sponsor: Massachusetts General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2026-11-01
Primary completion: 2028-02-28
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.